Приказ основних података о документу

dc.creatorBogdanović, Mihajlo
dc.creatorMladenović, Dragana
dc.creatorMojović, Ljiljana
dc.creatorĐuriš, Jelena
dc.creatorĐukić-Vuković, Aleksandra
dc.date.accessioned2024-03-12T14:24:47Z
dc.date.available2024-03-12T14:24:47Z
dc.date.issued2024
dc.identifier.issn1984-8250
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5558
dc.description.abstractThe last decade provided significant advances in the understanding of microbiota and its role in human health. Probiotics are live microorganisms with proven benefits for the host and were mostly studied in the context of gut health, but they can also confer significant benefits for oral health, mainly in the treatment of gingivitis. Postbiotics are cell-free extracts and metabolites of microorganisms which can provide additional preventive and therapeutic value for human health. This opens opportunities for new preventive or therapeutic formulations for oral administration. The microorganisms that colonize the oral cavity, their role in oral health and disease, as well as the probiotics and postbiotics which could have beneficial effects in this complex environment were discussed. The aim of this study was to review, analyse and discuss novel probiotic and postbiotic formulations intended for oral administration that could be of great preventive and therapeutic importance. A special attention has been put on the formulation of the pharmaceutical dosage forms that are expected to provide new benefits for the patients and technological advantages relevant for industry. An adequate dosage form could significantly enhance the efficiency of these products.
dc.publisherFaculdade de Ciencias Farmaceuticas
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200287/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200135/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.relationAlliance of International Science Organizations, project SparkGREEN (ANSO-CR-PP 2022-08).
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceBrazilian Journal of Pharmaceutical Sciences
dc.subjectLigilactobacillus salivarius
dc.subjectOral dosage forms
dc.subjectOral microbiota
dc.subjectPostbiotics
dc.subjectProbiotics
dc.titleIntraoral administration of probiotics and postbiotics: An overview of microorganisms and formulation strategies
dc.typearticle
dc.rights.licenseBY
dc.citation.volume60
dc.identifier.wos001176976100001
dc.identifier.doi10.1590/s2175-97902024e23272
dc.identifier.scopus2-s2.0-85186216964
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/15667/Intraoral_administration_of_pub_2024.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу